Active material: adgelon
When ATH: M09AX
CCF: Preparation, stimulates the regeneration of cartilage tissue
ICD-10 codes (testimony): M15
Manufacturer: ENDO-FARM AND PM UAB (Russia)
Solution for intra-articular injection in the form of a transparent, colorless liquid, without smell.
| 1 ml | |
| adgelon (0.01% solution glycoprotein in water for injection) | 10-9 ml |
Excipients: sodium chloride, calcium chloride, water d / and.
2 мл – ампулы (6) – упаковки ячейковые контурные (1) – пачки картонные.
2 мл – ампулы (10) – упаковки ячейковые контурные (1) – пачки картонные.
2 мл – ампулы (6) – пачки картонные.
2 мл – ампулы (10) – пачки картонные.
2 мл – флаконы (6) – пачки картонные.
2 мл – флаконы (10) – пачки картонные.
5 мл – флаконы (6) – пачки картонные.
5 мл – флаконы (10) – пачки картонные.
Preparation, stimulates the regeneration of cartilage tissue. The active substance of the drug is a glycoprotein, isolated from bovine serum.
The adhesive interaction of cells modulate drug mezenhimnogo origin and ingibiruet peroxide oxidation of lipids. Contributes to the rapid accumulation of masses of young cartilage cells and their differentiation, that leads to more rapid formation of replacement cartilage, restoration of smooth articular surface in the area of damage and improve joint mobility. In applying the drug populates the area of damaged cells and restore cartilaginous young cartilage tissue in definitivnom form, tk. has a place of its differentiation into layers, inherent in the original gialinovomu cartilage. With intra-articular injections produced by the cells of cartilage main substance has a more streamlined structure: it becomes the same dense, as in the normal functioning of the cartilage tissue.
Use Adgelona® causes reduction of pain after 2-3 injection.
The farmakokinetike drug Adgelon® not provided.
- Osteoarthritis of large joints.
The drug is indicated for intra-articular introduction. Solution imposed on 2 ml 2 times a week, курс лечения – 5-10 injection.
Side effects of the drug Adgelon® not disclosed.
-infections of the skin and tissue at the site of application;
- Hypersensitivity to the drug.
Data on the use of drugs Adgelon® Pregnancy and lactation (breast-feeding) not provided.
The simultaneous application Adgelona® with other drugs, solutions of antibiotics and CORTICOSTEROIDS. When combination therapy is recommended to comply with the time interval (few hours) between injections Adgelona® and other drugs.
Currently, the cases of drug overdose Adgelon® not reported.
Patient interaction drug Adgelon® with other drugs not covered.
The drug is released under the prescription.
The drug should be stored in a dry, protected from light, out of reach of children at a temperature of 4° c to 20° c. Shelf life - 2 year.
This site uses cookies and services to collect technical data from visitors to ensure performance and improve the quality of service.. By continuing to use our site, you automatically agree to the use of these technologies.
Read More